Leveraging the p53 signaling pathway as a radio-sensitization strategy in endometrial cancer
R. Vargas, A. Petty, A. Durmaz, K. Lin-Rahardja, O. Reizes, R. Debernardo, J. Scott
This study investigates how p53 signaling alterations affect radiotherapy response in endometrial cancer and explores p53 as a radio-sensitization strategy.
bioRxiv · Sep 6, 2022 · PreprintCancer Biology